Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|August 19, 2024
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumorsCarolina Reduzzi, Eleonora Nicolo', Surbhi Singhal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2026
Autologous T Cell Antigen Coupler Targeting HER2 (TAC01-HER2) in Advanced or Metastatic Solid TumorsEcaterina E Dumbrava, Daniel Olson, Mohamed A Gouda, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic MelanomaMohamed A Gouda, Bettzy Stephen, Yanyan Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
Journal of Immunotherapy and Precision Oncology|February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I TrialMirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine|February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell CarcinomaOmar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Journal for Immunotherapy of Cancer|June 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumorsMohamed H Derbala, Bettzy Stephen, Woochan Hwang, et al.
JCO Precision Oncology|February 6, 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1HMohamed A Gouda, Zihan Wei, Jordi Rodon, et al.
The Oncologist|March 14, 2026
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and EquityCarlos Torrado, Clark R Andersen, Lei Kang, et al.
Pageof 5